The following sections define the characteristics of CD8+Trm cells along with current research evaluating a role for CD8+Trm cells in antitumor therapy for four common digestive tract cancers, EC, GC, CRC, and HCC (Table 1). Here, CD8A is linked to hepatocellular carcinoma.